Status:
TERMINATED
Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Nationaal Kankerplan
Conditions:
Early Stage Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Surgical resection with mediastinal lymph node sampling is currently the therapy of choice for early stage (I-II) non-small cell lung cancer (NSCLC). Selected patients unwilling or unable to tolerate ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Proof of cT1a/b - 2a/b N0M0 NSCLC
- Informed Consent signed
- Resectable tumour
- Operable patient
- \> 18 years old
- men and women
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01138722
Start Date
May 1 2010
End Date
August 1 2011
Last Update
July 8 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Antwerp
Antwerp, Belgium
2
University Hospital Ghent
Ghent, Belgium